Tandem Labs
"Our ability to meet and exceed the expectations of our pharmaceutical clients is directly tied to the expertise and responsiveness of our staff. Management's top priority at Tandem Labs is to recruit the most qualified personnel and to provide them with a work environment and the resources that result in a high level of achievement and job satisfaction. Our focus on job fulfillment for each employee promotes internal stability, which in turn results in a thorough understanding of our client needs."
Ira S. DuBey, M.S., M.B.A.
Vice President and General Manager, Biotechnology Services
Ira S. DuBey joined Tandem Labs in December 2004. Mr. DuBey came to Tandem Labs with over 25 years of senior level management experience in laboratory-based businesses. From 1998 until joining Tandem, he directed the immunochemistry business for Covance Labs, Inc. in Chantilly, Virginia. Prior to Covance, Mr. DuBey held the position of department head of forensic toxicology for Quest Diagnostics, Inc. in Baltimore, Maryland. Before Quest Diagnostics, Mr. DuBey held senior management positions in the public sector, directing criminalistics laboratories in Maryland and New York.
James K. Wilfahrt, BSMT (ASCP), M.B.A.
Vice President, Operations
General Manager, Bioanalytical Services
James K. Wilfahrt has overall responsibility for the Utah, New Jersey, and Massachusetts bioanalytical operations. Mr. Wilfahrt joined Tandem Labs in 1991 as quality control manager. Mr. Wilfahrt held the positions of business development manager and operations manager prior to his current position. Before Tandem, Mr. Wilfahrt was the laboratory director for the division of infectious disease at Intermountain Healthcare in Salt Lake City, Utah.
Edward Brewer, M.S.
Senior Laboratory Director, Bioanalytical Division, New Jersey Facility
Edward Brewer leads laboratory operations for both discovery and GLP work at the New Jersey facility. He joined Tandem Labs in 1999 and has been involved in bioanalytical mass spectrometry since 1987. His expertise comes from experience within large pharma and contract research organizations. Mr. Brewer was formerly the section head of drug discovery at Advanced BioAnalytical Services, Inc.
Laura Cojocaru
Senior Laboratory Director, Bioanalytical Division, New Jersey Facility
Prior to Tandem Labs, Ms. Cojocaru served as the director of the bioanalytical department for Huntingdon Life Sciences. Previously, she was a senior manager in the bioanalytical department at Phoenix International Life Sciences in Montreal, Canada and a laboratory supervisor at Anachemia Canada, Inc., among others. Ms. Cojocaru brings more than 25-years of laboratory management experience to Tandem Labs. Ms. Cojocaru also possesses several inventor certificates for a number of procedures including one for obtaining L-Cysteine HCL and one for the extraction and purification of a hyaluronidase inhibitor of animal origin.
Roger Demers, B.Sc.
Group Leader, New Jersey Facility
Roger Demers is based in West Trenton, NJ. Mr. Demers has 17 years of experience with various mass spectrometry platforms, including 15 years with triple quadrupoles. He was one of the first in the world to use an API-III+ in 1989 (S/N 008) to quantitate NCEs in biological matrices commercially. Previously, Mr. Demers was the senior mass spectrometry scientist at Maxxam Analytics, Canada. In the past several years, Mr. Demers has developed and validated hundreds of bioanalytical methods on LC/MS/MS. His practical experience and expertise makes him one of the best method development scientists in the industry. He joined Tandem Labs, New Jersey in October 2004.
Lily Li , Ph.D.
Laboratory Director, Massachusetts Facility
Dr. Lily Li was the president of PharmaKD and is the newly appointed Laboratory Director of Tandem Labs-New England. Dr. Li joins Tandem Labs with significant expertise in biomarker discovery, high throughput protein binding assays, metabolite profiling and identification, pharmacokinetics, and antibody-based biotherapeutic assays. Prior to PharmaKD, Dr. Li was the director of Mass Spectrometry Analytics for Cantata Pharmaceuticals and the lead of High Throughput Analytics for Cereon Genomics/Monsanto, among others. Dr. Li earned her Ph.D. in lipid chemistry from Cornell University.
Xiguang (Lisa) Li , M.D.
Research Scientist, Biomarker and Immunoanalytical Division
Dr. Li adds nearly 35-years of senior research experience to Tandem Labs’ Biomarker and Immunoanalytical Division. Prior to Tandem Labs, Dr. Li was a research associate for Enzon Pharmaceuticals, Immunomedics, Johnson & Johnson, and Merck and Co., among others. Dr. Li brings with her a remarkable background in the development, validation, and sample analysis of assays using ELISA and other advanced technologies. She also has extensive experience in conducting flow cytometry experiments on cell lines as well as in immunogenicity and pharmacokinetics. Dr. Li earned her M.D. in Clinical Medicine from the Third Military Medical University of China in Chong Qing, P.R. China.
Min Meng, Ph.D.
Associate Laboratory Director, Utah Facility
Min Meng joined Tandem Labs in 1998 from the American Health Foundation. Her research prior to her appointment at Tandem Labs focused on identification and quantification of carcinogens, metabolites, DNA, and protein adducts by HPLC, GC/MS/MS, and LC/MS/MS. Dr. Meng leads on a group and oversees all method development, validation projects and pre-clinic sample analysis at the Salt Lake City facility.
Renuka C. Pillutla, Ph.D.
Laboratory Director, Method Development & Validation, Biomarker and Immunoanalytical Division
Dr. Pillutla joins Tandem Labs with more than ten years of senior research experience in laboratory-based settings. Prior to Tandem Labs, she was a senior research scientist in the Biological Methods Development Group for Global Biologics Supply Chain, LLC, a corporate division of Centocor and Johnson & Johnson. Prior to this position, Dr. Pillutla was a senior scientist in the Department of Molecular Biology for DGI Biotechnologies, Inc. in Edison, NJ. Dr. Pillutla comes to Tandem Labs with an extensive background in the drug discovery and biopharmaceutical arenas. Her expertise encompasses several areas ranging from target identification and target validation to assay development. She is also extremely familiar with ligand-binding studies and epitope mapping. Dr. Pillutla earned her Ph.D. in Biochemistry and Molecular Biology from the University of Medicine and Dentistry of New Jersey.
Scott A. Reuschel, M.S.F.S.
Laboratory Director, Bioanalytical Division, Utah Facility
Scott Reuschel joined Tandem Labs in November 1993 and is based in Salt Lake City, Utah. In his role as Associate Laboratory Director, Mr. Reuschel oversees the efficient, reliable operation of the laboratory; directs operational improvements and evaluations of new technologies, software platforms, and laboratory information management systems; and actively participates in strategic planning and process improvements. Mr. Reuschel has 15 years of experience in the bioanalytical field and is recognized as a technical expert in method development and validation. Prior to Tandem Labs, Mr. Reuschel worked at AccuTox Analytical Laboratories in Attalla, Alabama.
KC Van Horne, B.Sc.
Director, Research and Development
KC Van Horne joined Tandem Labs in August 2004 and is based in Salt Lake City, Utah. Mr. Van Horne has 22 years of experience in the bioanalytical field and is recognized in the industry as an expert in chromatography. His career has included positions as senior technical consultant, vice president of technology, president and CEO, and project leader. At Tandem Labs, Mr. Van Horne oversees the implementation of laboratory automation and expansion into other analytical services and products.
Michael VanTyne
Director, Information Systems
Michael VanTyne began working with Tandem Labs’ parent company in 1994 and currently oversees the Information Systems effort at Tandem Labs. Mr. VanTyne is an accomplished information systems professional with an outstanding track record in strategic planning, regulatory compliance for computerized systems, and technical direction. His achievements at Tandem Labs have included implementation of several comprehensive technologies and applications such Citrix Metaframe, the VelQuest SmartLab electronic lab notebook, Thermo Watson LIMS, and Waters NuGenesis SDMS. Mr. VanTyne has an Oracle Master Certification and has been a featured speaker on various subjects, including “System Ergonomics in a GLP Laboratory” at the International Meeting on Automated Compliance in May 2005.
Search